Future of IR Review Series

Multicenter Phase II Clinical Trial of Sorafenib Combined with TACE for Advanced Stage HCC (STAB Study)

PURPOSE To evaluate the safety and efficacy of combination therapy (TACE+ sorafenib) in patients with advanced stage HCC. STUDY DESIGN Open-label, non-randomized, single-arm multicenter phase II clinical trial. The primary endpoint was defined as the rate of completion of the treatment protocol (i.e., 2 months duration of sorafenib following TACE); Read more…

Med Student Section

Military Match and IR

Written by: Chris Choe, University of Tennessee College of Medicine MS3 Rose Miller, The Ohio State University College of Medicine, MS3   General Overview about Military Match While currently a rare topic of discussion, IR opportunities in the military are increasing. Medical students choose a career in military medicine for various reasons. For many Read more…